Search results
At least 6 in 10 U.S. adults will have cardiovascular disease in the next 30 years, new study finds....
Yahoo Life Style via AOL· 5 hours agoCardiologists break it down. Why are cardiovascular disease cases rising? There are several reasons...
Revolutionary Weight Loss: Largest Ever Obesity Study Showcases Semaglutide’s Promise
SciTechDaily· 3 days agoClinically meaningful weight loss was achieved by men and women of all races, ages, and body sizes,...
A chart shows the most common symptoms of colon cancer in people under 50, as cases in younger...
INSIDER via Yahoo News· 6 days agoExperts still don't know what's behind the rise in colon cancer, but ultraprocessed foods,...
Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron,...
Benzinga· 19 hours agoStructure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290,...
Obesity blamed for ‘disturbing’ rise in cancer cases among young
The Telegraph via Yahoo News· 2 days agoExperts fear the “disturbing” growth in early-onset cancer has been driven by the nation’s unhealthy...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 1 day agoThe MFS Growth Fund (MFEGX) is among the noteworthy holders. Eli Lilly Stock A chance has emerged to buy obesity play Eli Lilly after it surged back...
Rep. Sheila Jackson Lee reveals she's been diagnosed with pancreatic cancer. Here's what to know...
Yahoo Life· 18 hours agoStill...addition to undergoing testing for genetic mutations linked to the disease, including...
It’s not ok to be fat – and there’s nothing wrong with saying so
The Telegraph via Yahoo News· 6 hours agoPeople are puzzled by the startling rise in cancer among younger people, with the incidence rate up...
Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050
NewMediaWire via Yahoo Finance· 5 hours agoEmbargoed until 4 a.m. CT/5 a.m. ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older,...
Structure's obesity pill surpasses expectations in mid-stage study
Reuters via AOL· 1 day ago(Reuters) -Structure Therapeutics said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations ...